Drug Discovery World

NOVEMBER 16, 2022

In April 2021, life sciences solutions provider Molecular Devices launched its Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process. . 2D biology has been used by pharmaceutical researchers for decades. 2D vs 3D .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. Key opportunties. His advice? Up front collection and controlling your data!

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Predictive Oncology

FEBRUARY 7, 2023

That means a lot of wasted effort and resources for drugmakers given that even before a molecule enters Phase I trials, typically five to eight years of development have already been invested in the product. The next step was to validate the predictions and learn whether the drugs really produce a response in the specific tumor type.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

DrugBank

JUNE 27, 2024

Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 71

Drugs Pharma Companies Computational Chemistry Clinical Trials 71

Drug Discovery World

MAY 7, 2024

And it won’t be a quick move back into this market, by those big companies, but I think we need to keep pushing them.” The healthcare sector is trying to make it more appealing for pharma companies to develop antimicrobials. They don’t see it. They don’t respond to it.

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

Drug Discovery World

AUGUST 10, 2023

Remco Munnik (RM): Up to now, regulatory has always been the spider in the web within a pharmaceutical company – collecting all of the relevant information for submission of the registration: Clinical, CMC, administrative data, etc – then compiling a valid eCTD by the submission deadline.

Pharmaceutical Companies 245

Pharmaceutical Companies Production Science Pharma Companies 245

Drug Discovery World

NOVEMBER 15, 2022

If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . Synthetic libraries for antibody drug discovery .

DNA 246

DNA Engineering Drugs Vaccine 246

Drug Discovery World

JANUARY 26, 2023

However, coming off the back of high levels of return on investment (ROI) seen throughout Covid-19 and therefore 2021, was always going to be difficult for the pharma industry. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Production 52

Drug Target Review

MAY 23, 2023

9 Academic scientists researching natural products often struggle with the pitfalls of drug development. Pharmaceutical companies meanwhile need to reinvest in natural product research. Dorit also coordinates the EU-funded research project Algae4IBD.

Small Molecule 75

Small Molecule Drugs Production Pharma Companies 75

Drug Discovery World

AUGUST 16, 2022

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Cancer health disparities and underlying contributing factors .

Research 130

Research Clinical Trials Trials Drug Development 130

Elrig

APRIL 29, 2024

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Codon

FEBRUARY 13, 2024

The weakened dose of phages helped bacteria develop resistance, and the trial became yet another study that provided evidence phages are safe, but little more. Phage therapies matched to individual patients and requiring bleeding edge technologies may never be economically or logistically viable in low and middle-income countries.

Therapies 138

Therapies DNA Virus Clinical Trials 138

Drug Discovery World

SEPTEMBER 7, 2022

The drug discovery and development process is costly and arduous, offering no certainty of success which often rests on whether a company has chosen the correct drug molecule and target. As a result, AI can help address major drug development pain points, reducing costs and time to market,” he says. .

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

The Pharma Data

DECEMBER 30, 2020

. Another Biden plan opens up foreign markets for consumers to buy their prescription drugs and calls for limiting price increases on branded drugs and generics for drugs included in the Medicare program. BioMarin Pharmaceutical’s Roctavian for hemophilia B. M&A.

Vaccine 52

Vaccine FDA Trials Therapies 52